Posting of Circular

RNS Number : 4671O

Belluscura PLC

31 January 2023

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK version of the Market Abuse Regulation (EU) No.596/2014, which forms part of UK law by virtue of the European Union (Withdrawal) Act 2018 ("UK MAR").

Belluscura plc

("Belluscura", the "Company" or the "Group")

Posting of Circular

Belluscura plc (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, confirms that further to its announcement on 27 January 2023, a circular ("the Circular") and Notice of General Meeting has today been posted to shareholders.

General Meeting

The General Meeting will take place at 11.00 on 16 February 2023 at 15 Fetter Lane, London EC1A 4JN.

A copy of the Circular is available from the Company's website : wwww.belluscura.com

For further information please contact:

Belluscura plc	Tel: [phone]
Adam Reynolds, Chairman Robert Rauker, Chief Executive Officer Anthony Dyer, Chief Financial Officer
SPARK Advisory Partners Limited Nominated Adviser	Tel: [phone]
Neil Baldwin
Dowgate Capital Limited Broker and Bookrunner	Tel: [phone]
James Serjeant / Russell Cook
MHP Financial PR & Investor Relations	Tel: [phone]
Katie Hunt/Peter Lambie/ Matthew Taylor	email: [e-mail]

 

END

 

 

CIRFLFVELAILVIV